SCHEMBL14266751

SCHEMBL14266751

COC(=O)CNc1ccc([N+](=O)[O-])c(C)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.43
TXNRD1 Q16881 2/20 0.43
LMNA P02545 2/20 0.41
GSTP1 P09211 1/20 0.39
GSTM2 P28161 1/20 0.39
PDGFRB P09619 1/20 0.39
FGFR1 P11362 1/20 0.39
PDGFRA P16234 1/20 0.39
FLT1 P17948 1/20 0.39
FGFR3 P22607 1/20 0.39
KDR P35968 1/20 0.39
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA9 Q16790 2/20 0.38
CA14 Q9ULX7 2/20 0.38
ALDH1A1 P00352 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14287142 0.82 MAPT (0.41) MAPTALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL3254574 0.79 LMNA (0.52) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL15353518 0.78 MAPT (0.45) MAPTLMNAGSTM2ALDH1A1MEN1
SCHEMBL16712117 0.78 MAPT (0.52) MAPTTXNRD1LMNAGSTP1GSTM2
SCHEMBL2067384 0.77 RAB9A (0.48) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL5122680 0.76 MAPT (0.36) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL5971893 0.75 NUDT1 (0.48) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL2018202 0.75 CYP1A2 (0.53) MAPTLMNAALDH1A1MEN1KMT2A
SCHEMBL30051515 0.74 POLB (0.40) MAPTGSTP1GSTM2ALDH1A1MEN1
SCHEMBL10697343 0.74 MAPT (0.73) MAPTTXNRD1LMNAGSTP1GSTM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080058383-A1 Androgen Receptor Modulators KARO BIO AB (SE) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058383-A1 Androgen Receptor Modulators NR5A1, ESRRA, AR MAPT 3258/4885TXNRD1 562/4885LMNA 2695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.